4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Instil Bio, Inc. (TIL) operates in the Biotechnology industry and is headquartered in Dallas, United States with about 17 employees. Its market capitalization is roughly $52 million. In the fiscal year ended 2025-12-31, TIL reported $0M in revenue and ($71M) in net income.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($52M) | ($56M) | ($87M) | ($203M) | — |
| Net Income | ($71M) | ($74M) | ($156M) | ($223M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($6M) | ($10M) | ($15M) | ($13M) | ($14M) | — |
| Net Income | ($4M) | ($8M) | ($14M) | ($21M) | ($28M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $204M | $264M | $326M | $482M | — |
| Total Liabilities | $90M | $94M | $100M | $118M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TIL viewer.
About TickerBase · Data methodology & sources